Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 145.70 million as of April 24, 2025. Its market cap has decreased by -3.46% in one year.

Market Cap

145.70M

Enterprise Value

183.83M

Revenue

48.21M

Ranking

n/a

PE Ratio

10.11

Stock Price

7.13

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 145.70M, a decrease of -52.86%. That is a compound annual growth rate of -4.01%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	145.70M	-16.34%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	38.37M	-66.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Roche Holding AG	207.20B
Novartis AG	172.49B
Lonza Group AG	39.70B
Alcon	38.55B
Galderma Group AG	19.13B
Straumann Holding AG	15.90B
Sonova Holding AG	14.40B
Sandoz Group AG	14.33B

Market Cap Rankings